Bisphosphonates may increase peritoneal fibrinolytic activity by inhibiting the mevalonate pathway.
D000818:Animals; D004164:Diphosphonates / Q000494:pharmacology*; D005342:Fibrinolysis / Q000187:drug effects*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D008798:Mevalonic Acid / Q000037:antagonists & inhibitors*; D051379:Mice; D051381:Rats; D000267:Tissue Adhesions / Q000517:prevention & control
D004164:Diphosphonates; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008798:Mevalonic Acid